TCR2 Therapeutics Inc. (TCRR): Price and Financial Metrics

TCR2 Therapeutics Inc. (TCRR): $1.48

0.09 (-5.73%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add TCRR to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#292 of NR

in industry

TCRR Price/Volume Stats

Current price $1.48 52-week high $3.88
Prev. close $1.57 52-week low $0.82
Day low $1.48 Volume 3,913,300
Day high $1.63 Avg. volume 494,777
50-day MA $1.69 Dividend yield N/A
200-day MA $1.64 Market Cap 58.11M

TCRR Stock Price Chart Interactive Chart >


TCR2 Therapeutics Inc. (TCRR) Company Bio


TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.


TCRR Latest News Stream


Event/Time News Detail
Loading, please wait...

TCRR Latest Social Stream


Loading social stream, please wait...

View Full TCRR Social Stream

TCRR Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -73.71%
5-year -91.13%
YTD N/A
2023 0.00%
2022 -78.57%
2021 -84.93%
2020 116.60%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!